Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

New insight into extremely drug-resistant tuberculosis: using atomic force microscopy

A.A. Velayati, P. Farnia, M.A. Merza, G.K. Zhavnerko, P. Tabarsi, L.P. Titov, J. Ghanavei, P. Farnia, M. Setare, N.N. Poleschuyk, P. Owlia, M. Sheikolslami, R. Ranjbar, M.R. Masjedi
European Respiratory Journal 2010 36: 1490-1493; DOI: 10.1183/09031936.00064510
A.A. Velayati
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
P. Farnia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: pfarnia@hotmail.com
M.A. Merza
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
G.K. Zhavnerko
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
P. Tabarsi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
L.P. Titov
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. Ghanavei
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
P. Farnia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. Setare
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
N.N. Poleschuyk
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
P. Owlia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. Sheikolslami
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R. Ranjbar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M.R. Masjedi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

To the Editors:

We have recently documented the emergence of new forms of resistant tuberculosis (TB) bacilli (totally drug resistant (TDR)-TB or extremely drug-resistant (XXDR)-TB strains) among multidrug-resistant (MDR)-TB patients 1. XXDR-TB defines any case of TB with resistance to all first- and second-line anti-TB drugs whose smears and cultures remain positive despite prolonged therapy 1–3. At the cellular level of XXDR-TB strains, adaptation was observed and evaluated using transmission electron microscopy (TEM) 4, 5. In the exponential phase, three different cell populations were clearly distinguished: one displayed an ordinary pattern (70–80%), one exhibited a round or oval shape (15–20%), and the third displayed an extraordinarily thick cell wall (21–26 nm) with features similar to stationary or anaerobic dormant bacilli (5–7%) 3, 4. These adapted forms were detected in all XXDR-TB isolates, irrespective of their super families or genotype patterns. We tried to evaluate the different cell population of XXDR-TB strains in comparison to susceptible cells using atomic force microcsopy (AFM). To achieve this goal, we included sputum and culture positive specimens of the same patients in our study. AFM images were recorded in contact mode using an optical lever microscope equipped with a liquid cell (Nanoscope IV Multimode AFM; Veeco Metrology Group, Santa Barbara, CA, USA) 5. To image mycobacteria by AFM, the cells were immobilised by mechanical trapping onto isopore polycarbonate membrane (Millipore Corporation, Billerica, MA, USA), with pore size similar to the cell size. After filtering a concentrated cell suspension, the filter was gently rinsed with deionised water, carefully cut (1×1 cm) and attached to a steel sample puck (Veeco Metrology Group) using a small piece of adhesive tape. The mounted sample was transferred into the AFM liquid cell. Images were recorded in both height and deflection modes; using oxide-sharpened microfabricated Si3N4 cantilevers (microlevers; Veeco Metrology Group) with spring constant of 0.01 nm−1 6, 7. Through AFM observations, we confirmed the existence of oval shaped TB cells among XXDR-TB populations (fig. 1). All XXDR-TB bacilli showed prominent ultrastructural alterations (characteristic concentric striations and increased surface roughness) in comparison to susceptible bacilli. The average surface roughness of all adapted XXDR cells (14.8±1.4 nm on 200×200 nm height images) was higher than susceptible strains (8±2.5 nm on 200×200 nm height image) and the differences were statistically significant (table 1). Although not statistically significant, the adapted XXDR rod-shaped bacilli with thicker cell wall (∼20–26 nm) revealed a greater surface roughness (13.7±2.1 nm) than oval cells (10±0.8 nm) (fig. 2). We also noted that our AFM images did not show differences in ultrastructure of the cells isolated from sputum compared to the cell taken from Lowenstein–Jensen culture media. The observed striations and surface roughness in XXDR-TB bacilli were attributed to a direct effect of drugs and were co-related to the mode of arabinogalactan and protein assemblies in the cell wall envelope 8. Our overall observations were similar to studies by Altseens et al. 8 and Verbelen et al. 6, who reported that in vitro treatment of native Mycobacterium bovis bacilli Calmette–Guérin with first-line drugs induces the striations and surface roughness. These studies suggest that the efficiency of a given therapy may progressively change with the erosion of the envelope, which may not be in a positive manner. Additionally, in 2–3% of XXDR-TB bacilli, elaboration of long, tubular extensions of the cell envelope (length: 890 nm to 1 μm; diameter: 70–75 nm), which tapered towards one end, have also been observed (fig. 3). These appendages had very low surface roughness (2.5±1.2 nm) in comparison to both XXDR-TB and susceptible-TB cell envelopes. Therefore, we hypothesised that these structures were synthesised by the incorporation of new envelope materials that may comprise inner and outer membranes, peptidoglygcan and periplasmic space. For the first time, these tubular extensions have been seen in Mycobacterium tuberculosis and, at present, we do not know whether they are functional under genetic or environment controls. In our study, the investigated TB strains were isolated from XXDR-TB patients. All patients were subjected to second-line anti-TB drugs for 18–24 months with the following protocols: ofloxacin (400–800 mg·day−1); cycloserine (750–1,000 mg·day−1); prothionamide (750–1,000 mg·day−1); and amikacin (15 mg·kg−1·day−1 for 5 days per week, maximum 1 g·day−1). Therefore, further investigations are warranted in order to determine whether these morphological changes are induced by the combination therapy or certain specific anti-TB drugs. Finally, our observations have raised three questions. First, could Mycobacteria produce tubular structure on environmental constraints (effect of different drugs and/or low availability of nutrients)? Secondly, are persistent Mycobacteria also capable of producing such appendages? Thirdly, and most importantly, are such passages important for uptake of drugs inside the bacilli? In conclusion, XXDR-TB is a more serious and complex clinical concern than previously appreciated. Thus, urgent strategies are required to speed up novel anti-TB drugs toward resistant bacilli. It is important to understand the possibility of disease transmission through oval shape XXDR-TB bacilli. The size of these bacilli (300–900 nm) is smaller than rod-shaped bacilli (1.5–3 μm) and could easily escape attack from the body’s immune system. Therefore, if this could happen, then this is an issue requiring urgent attention from the global scientific community.

Figure 1–
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1–

In the exponential phase of growth, 15–20% of extremely drug-resistant tuberculosis (XXDR-TB) bacilli has an oval or rounded shape and is 300–900 nm in dimension. The average surface roughness of a rod-shaped bacilli was 13.7±1.5 nm in comparison to oval XXDR-TB cells which was 10±0.8 nm on 200×200 nm.

Figure 2–
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2–

The average surface roughness of all adapted extremely drug-resistant tuberculosis cells was higher (14.8±1.9 nm) than susceptible cells (8±2.5 nm) and the differences were statistically significant.

Figure 3–
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 3–

Of the extremely drug-resistant tuberculosis (XXDR-TB) bacilli, 2–3% had elaborated long, tubular extension of the cell envelope (length: 890 nm to 1 μm; diameter: 70–75 nm), with tapering towards the end. Tubular protrusion had low surface roughness (2.5±1.2 nm) in comparison to both the XXDR-TB and susceptible tuberculosis cell envelope.

View this table:
  • View inline
  • View popup
Table 1– Average surface roughness in susceptible and extremely drug-resistant tuberculosis (XXDR-TB) cells

Acknowledgments

The authors wish to thank the staff of the Microbiology Unit at the Republican Research and Practical Centre for Epidemiology and Microbiology (Minsk, Belarus). We are also sincerely thankful to the TB laboratory staff at the Mycobacteriology Research Centre/NRITLD (Tehran, Iran).

Footnotes

  • Support Statement

    This study was sponsored by a grant from the Ministry of Health and Medical Education, Deputy of Research (2009–2010; Tehran, Iran).

  • Statement of Interest

    None declared.

  • ©ERS 2010

REFERENCES

  1. ↵
    1. Velayati AA,
    2. Masjedi MR,
    3. Farnia P,
    4. et al
    . Emergence of new forms of totally drug-resistant tuberculosis bacilli: super extensively drug-resistant tuberculosis or totally drug resistant strains in Iran. Chest 2009; 136: 420–425.
    OpenUrlCrossRefPubMedWeb of Science
    1. Migliori GB,
    2. De Iaco G,
    3. Besozzi G,
    4. et al
    . First tuberculosis cases in Italy resistant to all tested drugs. Euro Surveill 2007; 12: 20–
    OpenUrl
  2. ↵
    1. Migliori GB,
    2. Loddenkemper R,
    3. Blasi F,
    4. et al
    . 125 years after Robert Koch's discovery of the tubercle bacillus: the new XDR-TB threat. Is “science” enough to tackle the epidemic? Eur Respir J 2007; 29: 423–427.
    OpenUrlFREE Full Text
  3. ↵
    1. Velayati AA,
    2. Farnia P,
    3. Masjedi MR,
    4. et al
    . Totally drug-resistant tuberculosis starins: evidence of adaptation at the cellular level. Eur Respir J 2009; 34: 1–3.
    OpenUrlFREE Full Text
  4. ↵
    1. Velayati AA,
    2. Farnia P,
    3. Masjedi MR,
    4. et al
    . Differences in cell wall thickness between resistant and non resistant of Mycobacterium tuberculosis: using transmission electron microscopy. J Chemother 2009; 55: 303–307.
    OpenUrlCrossRef
  5. ↵
    1. Verbelen C,
    2. Dupres V,
    3. Menozzi FD,
    4. et al
    . Ethambutol-induced alterations in Mycobacterium bovis BCG imaged by atomic force microscopy. FEMS Microbiol Lett 2006; 264: 192–197.
    OpenUrlAbstract/FREE Full Text
  6. ↵
    1. Kasas S,
    2. Ikai A
    . A method for anchoring round shaped cells for atomic force microscope imaging. Biophys J 1995; 68: 1678–1680.
    OpenUrlCrossRefPubMedWeb of Science
  7. ↵
    1. Alsteen D,
    2. Verbelen C,
    3. Dague E,
    4. et al
    . Organization of the mycobacterial cell: a nanoscale view. Pflugers Arch 2008; 456: 117–125.
    OpenUrlCrossRefPubMedWeb of Science
View Abstract
PreviousNext
Back to top
View this article with LENS
Vol 36 Issue 6 Table of Contents
European Respiratory Journal: 36 (6)
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
New insight into extremely drug-resistant tuberculosis: using atomic force microscopy
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
New insight into extremely drug-resistant tuberculosis: using atomic force microscopy
A.A. Velayati, P. Farnia, M.A. Merza, G.K. Zhavnerko, P. Tabarsi, L.P. Titov, J. Ghanavei, P. Farnia, M. Setare, N.N. Poleschuyk, P. Owlia, M. Sheikolslami, R. Ranjbar, M.R. Masjedi
European Respiratory Journal Dec 2010, 36 (6) 1490-1493; DOI: 10.1183/09031936.00064510

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
New insight into extremely drug-resistant tuberculosis: using atomic force microscopy
A.A. Velayati, P. Farnia, M.A. Merza, G.K. Zhavnerko, P. Tabarsi, L.P. Titov, J. Ghanavei, P. Farnia, M. Setare, N.N. Poleschuyk, P. Owlia, M. Sheikolslami, R. Ranjbar, M.R. Masjedi
European Respiratory Journal Dec 2010, 36 (6) 1490-1493; DOI: 10.1183/09031936.00064510
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • Respiratory infections and tuberculosis
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Drug concentration in lung tissue in MDR-TB
  • Obesity in COPD: the effect of water-based exercise
  • Burden of CAP in Italian general practice
Show more Letters

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society